Fifth Third Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fifth Third Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$351K	Sell	2,229 -23	-1%	-$3.63K	0.01%	680
2026 Q2	$356K	Buy	2,252 +188	+9%	+$25.4K	0.01%	620
2026 Q1	$264K	Buy	2,064 +360	+21%	+$44.9K	0.01%	655
2025 Q4	$208K	Buy	+1,704	New	+$195K	0.01%	743

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Fifth Third Wealth Advisors's XBI Position: Q3 2026 in Review

Fifth Third Wealth Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1% in Q3 2026, selling an estimated $3.63K and leaving 2,229 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #680.

Fifth Third Wealth Advisors first reported a position in XBI in Q4 2025 and has held it in 4 quarters since. The position peaked at $356K in Q2 2026. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Fifth Third Wealth Advisors held 2,229 shares of State Street SPDR S&P Biotech ETF worth $351K as of Q3 2026.
Fifth Third Wealth Advisors sold 23 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $3.63K.
State Street SPDR S&P Biotech ETF made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #680 holding.
Fifth Third Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 4 quarters since.
Fifth Third Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $356K in Q2 2026.
820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.